GCG and heart failure: One retrospective cohort study [17], including 13,185 patients and with a median follow-up of four years, reported that GLP-1 agonists were associated with a non-significant increase in heart failure versus sulfonylureas (adjusted HR 1.10, 95 % CI 0.99 to 1.22).